- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-CD47
CD47 Monoclonal Antibody for WB, IF/ICC, ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
Humain et plus (2)
Applications
WB, IF/ICC, ELISA
Conjugaison
Non conjugué
CloneNo.
1E1D8
N° de cat : 66304-1-Ig
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules SKOV-3, cellules A549, cellules HaCaT, cellules HeLa, cellules HT-1080, cellules HUVEC, cellules Jurkat, cellules K-562, cellules MDA-MB-231, cellules NCI-H1299, cellules TF-1, tissu placentaire humain |
| Résultats positifs en IF/ICC | cellules A549, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:5000-1:50000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 17 publications below |
| IF | See 3 publications below |
| FC | See 1 publications below |
Informations sur le produit
66304-1-Ig cible CD47 dans les applications de WB, IF/ICC, ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Réactivité citée | rat, Humain, souris |
| Hôte / Isotype | Mouse / IgG2b |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | CD47 Protéine recombinante Ag14132 |
| Nom complet | CD47 molecule |
| Masse moléculaire calculée | 323 aa, 35 kDa |
| Poids moléculaire observé | 50-55 kDa |
| Numéro d’acquisition GenBank | BC010016 |
| Symbole du gène | CD47 |
| Identification du gène (NCBI) | 961 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
CD47, also known as integrin-associated protein (IAP), is a member of the immunoglobulin superfamily containing a five-pass transmembrane attachment. CD47 is heavily glycosylated and widely expressed by hematopoietic and nonhematopoietic cells. CD47 interacts with several membrane integrins and also acts a receptor for thrombospondin (THBS1). It is involved in a range of cellular processes, including apoptosis, proliferation, adhesion, and migration. CD47 also functions as a ligand for signal regulatory protein-α (SIRPα). Upon binding CD47, SIRPα initiates a signaling cascade that results in the inhibition of phagocytosis.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for CD47 antibody 66304-1-Ig | Download protocol |
| IF protocol for CD47 antibody 66304-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Redox Biol Endothelial transferrin receptor 1 contributes to thrombogenesis through cascade ferroptosis | ||
ACS Appl Mater Interfaces Dual-Regulated Biomimetic Nanocomposites For Promoted Tumor Photodynamic Immunotherapy | ||
J Control Release Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers. | ||
J Nanobiotechnology Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC. | ||
RSC Adv Seedless preparation of Au nanorods by hydroquinone assistant and red blood cell membrane camouflage |




